Can NMN Revolutionize Lung Health? Unveiling New Research Insights

Lung diseases, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), are prevalent health problems that impact millions across the United States. 

Based on current estimates, over 34 million American adults live with a chronic lung condition like asthma or COPD, which includes emphysema and chronic bronchitis. Asthma alone affects more than 25 million Americans, including over 4 million children. Additionally, around 9 million adults in the US have been diagnosed with COPD, an obstructive lung disease that gradually makes breathing more challenging. Tobacco-induced diseases, including those caused by secondhand smoke exposure, claim nearly half a million lives in the U.S. annually. 

Given these alarming statistics, it's clear that the quest for effective treatment strategies for lung disease is of the utmost importance. Although several treatments are available, they often have their own drawbacks and limitations, such as potential side effects or reduced efficacy over time. This highlights the necessity for continual exploration of more comprehensive, safer, and more effective solutions for lung disease management.

One promising area of research in this ongoing search is Nicotinamide Mononucleotide (NMN), a molecule crucial for cellular energy metabolism that has been implicated in the regulation of lung health. Emerging research is beginning to reveal the potential benefits of NMN, particularly for individuals struggling with chronic lung diseases.

In this article, we aim to:

Explore the complex relationship between NMN and lung diseases.

Discuss the potential benefits of NMN supplementation for individuals with chronic lung diseases.

Review the latest research findings about the role of NMN in managing these chronic conditions.

By investigating these areas, we hope to shed light on the promising potential of NMN supplementation as a supportive treatment in the comprehensive landscape of lung disease care and management. [1] 

What Are Lung Diseases? 

Lung diseases, which affect tens of millions in the U.S., arise from issues in the respiratory system caused by smoking, infections, and genetics. 

Diseases impacting the airways, such as asthma and COPD, lead to breathing difficulties due to inflammation or mucus build-up. Alveoli-impacting conditions like pneumonia and tuberculosis result from infections or harmful inhalations, leading to fluid leakage or lung tissue damage.

Diseases like sarcoidosis and pulmonary fibrosis can also impact the interstitium, the lining between alveoli. Blood vessel conditions in the lungs, such as pulmonary embolism and hypertension, lead to symptoms like shortness of breath and chest pain. 

Lung diseases can also affect the pleura and the chest wall, leading to obesity hypoventilation syndrome, and neuromuscular disorders. 

Our next section will explore the relationship between these lung diseases and Nicotinamide Mononucleotide (NMN). [2] 

The Intriguing Science of NMN and Lung Health 

Emerging research hints at the promising health benefits of Nicotinamide Mononucleotide (NMN), particularly for our lungs.

Studies suggest NMN might protect lungs from pollution-induced damage, aid lung health as we age, and even contribute to preventing COVID-19 in older adults. 

But remember, while promising, these findings require more investigation. Join us as we explore the captivating potential of NMN for lung health.

NMN Shields Lungs from Pollution-Induced Damage

A recent study published in the Environmental Health Perspectives Journal in 2023 suggests that NMN might help protect our lungs from air pollution.

Lots of people live in cities with air filled with tiny harmful bits from car exhaust and factory smoke. Over time, these pollutants can damage our lungs and weaken our immune system. Research from China found that these pollutants lower levels of a health-important molecule, NAD+, leading to lung damage and harmful immune response.

The study showed that if mice were given NMN, it boosted their NAD+ levels and they avoided severe lung damage from pollution. The research also found that NMN lowered the harmful immune response caused by pollution.

The researchers found that giving NMN to mice protected them from lung damage caused by 16 weeks of pollution exposure. This research suggests that NMN might be a useful way to protect our lungs from pollution. However, more studies are needed to confirm these results and see if they apply to humans. [3] 

NMN Helps Protect Aging Lungs

As we age, lung diseases can develop when crucial breathing cells, alveolar epithelial cells (AECs), stop working well. Chinese scientists, led by Wei, found that NMN can support these cells and maintain lung health in older mice, according to their study published in MedComm in 2021.

NMN is linked to nicotinamide adenine dinucleotide (NAD+), a key molecule for metabolism and DNA health, which decreases in levels as we age. The scientists found that NMN reduced aging-related proteins in mouse lungs and lessened the number of senescent cells in lab experiments, suggesting that NMN can protect lungs during aging.

Finally, the researchers exposed mice to lung-damaging antibiotics and found that NMN protected the lungs, reduced inflammation, and prevented scarring. The team concluded that NMN could alleviate AECs senescence and potentially prevent and reduce age-related lung diseases and injuries. [4] 

NMN Reduces Lung Damage Caused by Smoking

Smoking contributes to lung diseases like idiopathic pulmonary fibrosis (IPF), which is linked to lung cell scarring and cell senescence. Researchers Zhang and his team published in the Free Radical Biology and Medicine in 2021 discovered that NMN could stimulate the cell cleanup process, autophagy, in cells damaged by cigarette smoke. Experiments in mice showed that NMN reduced harmful oxygen-containing molecules and cell senescence, potentially slowing IPF progression.

The researchers found that smoking caused cell senescence and impaired autophagy, leading to a buildup of senescent cells. However, using NMN restored autophagy and reduced the harmful effects of smoking, suggesting its potential to slow IPF onset. 

They concluded, "SIRT1 activator and supplementation of NAD+ with its precursor could restore SIRT1 activity and prevent [lung cell] senescence." Further research is needed to validate these findings in smokers. [5] 

NMN Reduces Lung Damage Caused by Breathing in Dust

Aging and exposure to harmful substances like dust can damage our lungs. A Chinese study published in Nutrients in 2023 suggests that NMN could mitigate lung damage caused by silica dust. 

The research on male mice demonstrated that NMN treatment reduced lung damage, inflammation, and oxidative stress, while increasing glutathione, a molecule that protects against reactive oxygen species. NMN also preserved the structure of alveoli, the small air sacs essential for oxygen absorption.

NMN's benefits extend beyond silicosis; it has shown promise in treating lung injuries from sepsis or smoking. Although promising in mice, further research is needed in humans to fully understand NMN's benefits. [6] 

NMN May Help Heal Lung Damage in Mice

Aging increases our risk for serious infections like sepsis, leading to lung damage. A Chinese study published in the Journal of Surgical Research in 2022 demonstrated that NMN linked to reducing inflammation, can treat lung damage in mice. The research found that NMN lessened lung damage, inflammation, and oxidative stress. 

The study induced lung damage in mice using lipopolysaccharide (LPS), then treated them with NMN, which effectively reduced the damage. The research suggests that NMN may also help treat human lung damage and potentially slow down lung aging. However, further studies are required. [7] 

NMN Might Help Prevent COVID-19 in Older Adults, Study Finds

COVID-19 affects older adults more severely, possibly due to DNA damage that comes with aging. A study from the Beijing Institute of Biotechnology published in Aging Cell in 2022 found that the virus more easily enters DNA-damaged human lung cells. However, treating mice with NMN helped protect DNA and prevent virus entry. 

The research showed that DNA-damaged cells had more ACE2 receptors, the virus's entry point. NMN treatment in old mice exposed to a version of the SARS-CoV-2 virus reduced these receptors and lowered the virus amount in their lungs. Thus, NMN could potentially protect older adults from severe COVID-19. [8] 

Conclusion

Citations: